tiprankstipranks

RenovoRx Delays Yearly Report Filing

Story Highlights

RenovoRx ( (RNXT) ) has released a notification of late filing.

Protect Your Portfolio Against Market Uncertainty

RenovoRx, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the need to complete certain technical accounting requirements with both current and former auditing firms. The company expects to file the report within the fifteen-day grace period allowed by the SEC. RenovoRx anticipates recognizing initial revenue from its RenovoCath commercial efforts and a slight decrease in net loss due to reduced expenses. These figures are still under review and may change upon final filing. The notification was signed by Ronald B. Kocak, Vice President, Controller, and Principal Accounting Officer, indicating ongoing compliance efforts.

More about RenovoRx

YTD Price Performance: -26.47%

Average Trading Volume: 139,701

Technical Sentiment Signal: Buy

Current Market Cap: $35.57M

For detailed information about RNXT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App